Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
NCT01265030Phase 2Completed
- Sponsor
- MaineHealth
- Start
- Feb 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in desmoid-type fibromatosis (DF), sponsored by MaineHealth. Started Feb 2014; status: completed.
02
Drugs
sirolimus
03
Conditions
desmoid-type fibromatosis (DF)
Beyond the preview
Go deeper on NCT01265030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265030.